(Q40847993)

English

Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Jie Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Hui-Ying Fan

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Zhen Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Juan Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Jiao Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Jian-Ni Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Yu Ye

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Ming Liao

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

23 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

622-629

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

The changing nature of avian influenza A virus (H5N1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Novel H5 clade 2.3.4.6 viruses with both α-2,3 and α-2,6 receptor binding properties may pose a pandemic threat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Novel reassortant H5N5 viruses bind to a human-type receptor as a factor in pandemic risk.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Avian influenza vaccination: the experience in China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Scientific barriers to developing vaccines against avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

M2e-Based Universal Influenza A Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Advances and challenges in mucosal adjuvant technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Effective CD8(+) T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Non-toxic derivatives of LT as potent adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Cell-mediated protection in influenza infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.12.039

7 January 2021

based on heuristic

inferred from DOI database lookup

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

10.1016/J.VACCINE.2015.12.039

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40847993&oldid=1908573822"